Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	15.06	27.99	24.33
Graham Fair Price	-10.06	9.44	10.50
PEG	-176.17	-0.89	-0.32
Price/Book	10.67	1.03	0.93
Price/Cash Flow	24.44	41.81	-33.60
Prices/Earnings	38.09	17.74	12.85
Price/Sales	5.00	3.10	2.96
Price/FCF	24.44	41.81	-33.60
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-9.26	0.32	0.35
Operating Margin	-19.91	0.07	0.08
ROA	-20.37	< 0.005	< 0.005
ROE	0.02	0.01	-19.85
ROIC	0.01	0.01	-21.82
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.12	0.04	236.38
Dividends QOQ	0.09	< 0.005	-91.74
EBIT QOQ	0.11	-0.15	29.32
EPS QOQ	-0.40	-0.20	50.00
FCF QOQ	-1.27	1.90	49.27
Revenue QOQ	-0.08	0.07	-20.56
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	124.61	134.70	8.10
Days Sales Outstanding (DSO)	99.08	93.81	-5.32
Inventory Turnover	0.72	0.67	-7.49
Debt/Capitalization	0.37	0.34	-8.63
Quick Ratio	0.50	0.44	-12.83
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	16.46	16.54	0.46
Cash	3.05	2.23	-26.95
Capex	-0.50	-0.43	15.29
Free Cash Flow	-0.46	0.41	-10.65
Revenue	5.17	5.48	5.89
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.89	0.90	0.89
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	8.03	8.16	1.59
Naive Interpretation	Member

06 - Financial Health · Bad

Rating